Opportunity Information: Apply for RFA CA 23 021

The funding opportunity titled "NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)" (Funding Opportunity Number RFA-CA-23-021) is a National Cancer Institute (NCI) cooperative agreement intended to build the central statistical and data infrastructure for a new, national Cancer Screening Research Network (CSRN). This FOA is one of three companion announcements that together establish the broader CSRN effort. The core purpose of the CSRN is to enable and run multi-center cancer screening clinical trials and related studies at a national scale, with an emphasis on research that improves early detection and tests emerging screening approaches in real-world healthcare environments. The long-term public health aim is to reduce cancer incidence and lessen cancer-related illness and deaths by improving how screening is performed, evaluated, and implemented.

Within that larger network, the Statistics and Data Management Center is meant to serve as the backbone for trial operations that depend on rigorous study design, high-quality data collection, and credible analysis. In practical terms, the center funded under this FOA would typically be responsible for functions like statistical leadership for protocol development, randomization and trial design support, data coordination across multiple participating sites, database development and maintenance, data quality monitoring, harmonization of data elements, interim and final analyses, reporting, and support for regulatory-compliant data practices. Because the activity is listed as "Clinical Trial Required" under a UG1 cooperative agreement mechanism, the work is expected to be closely coordinated with NCI program staff and aligned with the execution of multi-site screening trials and studies rather than being purely observational or purely methodological.

A defining feature of the CSRN described in the announcement is its intent to leverage large and diverse populations who are already receiving routine care across many types of healthcare settings. That focus signals a strong interest in studies that are feasible in everyday clinical practice, can recruit broadly across different communities, and can evaluate screening modalities as they might actually be deployed. The network is positioned to address questions about improving existing screening pathways, increasing appropriate screening uptake, reducing disparities, and assessing new or emerging screening tests or strategies, all using rigorous multi-center study designs.

Eligibility is broad and includes many common U.S.-based applicant types: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, the opportunity makes clear that non-U.S. entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed, reinforcing that the funded infrastructure and activities must be domestic.

Administratively, the sponsoring agency is the National Institutes of Health (NIH) with NCI leadership, and the program is categorized under Education and Health. The CFDA numbers associated with the opportunity are 93.393, 93.394, and 93.399. The original closing date listed is February 28, 2023, and the FOA was created on November 17, 2022. The award ceiling and expected number of awards are not specified in the provided listing, which typically means applicants would need to consult the full FOA text for budget guidance, project period expectations, and the exact scope of required center activities and deliverables.

Overall, this announcement is aimed at establishing a centralized, network-wide statistics and data management hub that can support complex, multi-site cancer screening trials, ensure data integrity and comparability across settings, and generate high-confidence evidence about screening approaches that can improve early detection and ultimately reduce the burden of cancer.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.394, 93.399.
  • This funding opportunity was created on 2022-11-17.
  • Applicants must submit their applications by 2023-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 23 021

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)

Previous opportunity: North West Province Orphans and Vulnerable Children Activity

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 23 021

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 23 021) also looked into and applied for these:

Funding Opportunity
NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required) Apply for RFA CA 23 022

Funding Number: RFA CA 23 022
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) Apply for PAR 23 052

Funding Number: PAR 23 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) Apply for PAR 23 051

Funding Number: PAR 23 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 23 004

Funding Number: RFA CA 23 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 003

Funding Number: RFA CA 23 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 005

Funding Number: RFA CA 23 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 23 009

Funding Number: RFA CA 23 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 23 008

Funding Number: RFA CA 23 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 23 007

Funding Number: RFA CA 23 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 23 010

Funding Number: RFA CA 23 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 23 002

Funding Number: RFA CA 23 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 23 006

Funding Number: RFA CA 23 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 23 011

Funding Number: RFA CA 23 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) Apply for PAR 23 058

Funding Number: PAR 23 058
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional) Apply for RFA DA 24 010

Funding Number: RFA DA 24 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) Apply for PAR 23 059

Funding Number: PAR 23 059
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Co-infection and Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 23 055

Funding Number: PAR 23 055
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 23 056

Funding Number: PAR 23 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Mechanisms and Targets at the Intersection of HIV and Substance Use (R21 Clinical Trials Not Allowed) Apply for RFA DA 24 014

Funding Number: RFA DA 24 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 013

Funding Number: RFA DA 24 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 23 021", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: